These are top 10 stocks traded on the Robinhood UK platform in July
On Monday, Benchmark analyst Bill Sutherland maintained a Buy rating and a $165.00 price target for Huron Consulting Group (NASDAQ:HURN). Sutherland’s endorsement comes as Huron prepares to announce its earnings results on Tuesday after the market closes. According to InvestingPro data, the company maintains a "GREAT" financial health score and has delivered impressive returns, with the stock up 43% over the past year. At the company’s Investor Day on March 25, management confidently reiterated their financial guidance for FY25, suggesting a conservative yet promising outlook for the current year. The projected midpoint for revenue and Adjusted EBITDA growth stands at 9% (7.6% organic) and 17%, respectively, outpacing consensus estimates. With a PEG ratio of just 0.2, InvestingPro analysis suggests the stock is trading at an attractive valuation relative to its growth prospects. Discover more valuable insights with InvestingPro’s comprehensive research report, available for over 1,400 US stocks.
The company’s prospects appear particularly strong in the healthcare sector, where shifts in clinical reimbursement models, adjustments in NIH funding for research, stricter Medicaid eligibility, and changes to certain organizations’ tax exemption statuses present opportunities. Huron’s guidance includes an Adjusted EBITDA margin expansion of 70 to 120 basis points, attributed to strategic pricing initiatives, disciplined expense management, AI-driven efficiencies, the utilization of an expanded global delivery platform, and consultant compensation incentives aligned with margin goals.
Sutherland highlights the visibility of the margin targets, noting management’s influence over internal investment levels each year. Despite Huron’s stock falling 19% from its peak on February 28th, the upcoming earnings report is anticipated to provide a stabilizing effect in a fluctuating market environment. The company’s strategic approach, coupled with a favorable macro setup, positions Huron to potentially rebound from its recent decline.
In other recent news, Huron Consulting Group reported strong fourth-quarter 2024 financial results, with earnings per share of $1.90, surpassing analyst estimates of $1.52. The company’s revenue for Q4 reached $399.31 million, exceeding the consensus estimate of $379.99 million and showing significant growth from $339.2 million in the same quarter the previous year. Huron’s full-year 2024 results also showed a 9.1% increase in revenues to $1.49 billion and an 86.7% increase in net income to $116.6 million. Following these results, Benchmark analyst Bill Sutherland and Truist Securities analyst Tobey Sommer both raised their price targets to $165, maintaining Buy ratings due to Huron’s strong performance and potential in healthcare and education sectors.
Additionally, Huron announced an increase in its share repurchase program, authorizing a total of $700 million in buybacks, a $200 million increase from the previous amount. This move is part of Huron’s capital allocation strategy aimed at delivering value to shareholders. Truist Securities also maintained a Buy rating and increased their price target to $180, highlighting Huron’s resilience due to its diverse revenue streams and potential growth in digital offerings. Analysts from Truist noted Huron’s strategic positioning to navigate market challenges and leverage artificial intelligence in its services. These developments reflect Huron’s strategic initiatives and financial health, as the company continues to focus on growth and shareholder returns.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.